The world of artificial intelligence is constantly evolving, and OpenAI’s recent transition to a for-profit model has piqued the interest ...

The massive PBM’s announcement comes as the drug middlemen attempt to lessen regulatory scrutiny. The company also said it will move to a cost-plus reimbursement model for in-network pharmacies.

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

The Department of Health and Human Services (HHS) announced on Friday it had reached an agreement with Pfizer to ensure continued access to the antiviral Paxlovid for the next few years as it prepares ...

For decades, the healthcare industry has been talking about the need to transition away from the traditional fee-for-service reimbursement model, which pays doctors for every piece of care they ...